Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$33.79
+2.87%
Mkt Cap $6.49B
EPS — Estimate vs Actual
Mkt Cap
$6.49B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78
NASDAQ·Healthcare·Biotechnology
$33.79
+2.87%
Mkt Cap $6.49B
Mkt Cap
$6.49B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78